Drexel Morgan & Co’s Otis Worldwide OTIS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$331K Hold
4,288
0.05% 54
2025
Q4
$375K Hold
4,288
0.06% 51
2025
Q3
$392K Hold
4,288
0.06% 47
2025
Q2
$425K Hold
4,288
0.08% 45
2025
Q1
$443K Hold
4,288
0.09% 44
2024
Q4
$397K Hold
4,288
0.08% 46
2024
Q3
$446K Hold
4,288
0.08% 46
2024
Q2
$413K Hold
4,288
0.09% 44
2024
Q1
$426K Hold
4,288
0.09% 43
2023
Q4
$384K Hold
4,288
0.09% 43
2023
Q3
$344K Hold
4,288
0.09% 42
2023
Q2
$382K Hold
4,288
0.1% 42
2023
Q1
$362K Hold
4,288
0.09% 43
2022
Q4
$336K Hold
4,288
0.07% 42
2022
Q3
$274K Hold
4,288
0.07% 43
2022
Q2
$303K Hold
4,288
0.08% 42
2022
Q1
$330K Hold
4,288
0.1% 42
2021
Q4
$373K Hold
4,288
0.11% 42
2021
Q3
$353K Hold
4,288
0.11% 40
2021
Q2
$351K Hold
4,288
0.1% 59
2021
Q1
$294K Sell
4,288
-1
-0% -$65 0.07% 89
2020
Q4
$290K Hold
4,289
0.08% 87
2020
Q3
$268K Sell
4,289
-3,212
-43% -$196K 0.09% 83
2020
Q2
$427K Buy
+7,501
New +$389K 0.16% 68

Other funds holding OTIS

Drexel Morgan & Co's OTIS Position: Q1 2026 in Review

Drexel Morgan & Co held its Otis Worldwide (OTIS) position steady in Q1 2026 at 4,288 shares worth $331K. The position accounts for 0.05% of the portfolio, ranked #54.

Drexel Morgan & Co first reported a position in OTIS in Q2 2020 and has held it in 24 quarters since. The position peaked at $446K in Q3 2024. 1,234 funds tracked by Wall St. Rank hold OTIS as of Q1 2026.

  • Drexel Morgan & Co held 4,288 shares of Otis Worldwide worth $331K as of Q1 2026.
  • Drexel Morgan & Co left its Otis Worldwide share count unchanged in Q1 2026.
  • Otis Worldwide made up 0.05% of Drexel Morgan & Co's portfolio in Q1 2026, its #54 holding.
  • Drexel Morgan & Co first reported a position in Otis Worldwide in Q2 2020 and has held it in 24 quarters since.
  • Drexel Morgan & Co's Otis Worldwide position peaked at $446K in Q3 2024.
  • 1,234 funds tracked by Wall St. Rank held Otis Worldwide as of Q1 2026.

Based on Drexel Morgan & Co's 13F filing for Q1 2026, filed 11 May 2026.